Vascular Dysfunction in Aging: Potential Effects of Resveratrol, an Anti- Inflammatory Phytoestrogen
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
989-996
Author(s):
Nazar Labinskyy, Anna Csiszar, Gabor Veress, Gyorgyi Stef, Pal Pacher, Gabor Oroszi, Joseph Wu and Zoltan Ungvari
Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1173-1193
Author(s):
G. M. Lenato and G. Guanti
Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1227-1235
Author(s):
Maurizio Memeo, Arnaldo Scardapane, Amato A.S. Ianora, Carlo Sabba and Giuseppe Angelelli
The Need for an Interdisciplinary Network of Investigations on HHT
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1249-1251
Author(s):
G. Pasculli, G. Sallustio and C. Sabba
Editorial
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1253-1253
Author(s):
Peter W. Radke
Biology and Pharmacology of the Platelet P2Y12 Receptor
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1255-1259
Author(s):
Robert F. Storey
Clopidogrel Resistance: Implications for Coronary Stenting
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1261-1269
Author(s):
Paul A. Gurbel, Wei C. Lau, Kevin P. Bliden and Udaya S. Tantry
Thienopyridines and Statins: Assessing a Potential Drug-Drug Interaction
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1271-1280
Author(s):
H. Neubauer and A. Mugge
The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1287-1291
Author(s):
Andreas Franke and Harald P. Kuhl
Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
1293-1297
Author(s):
Hans-Christoph Diener